Acquiring Company
Dechra
Acquired Company
Gallant
Description
Dechra has completed its acquisition of Gallant Pet, Inc., an animal health biotechnology company. This strategic move aims to enhance veterinary care through regenerative medicine and broaden treatment options for complex conditions in pets.
Other recent acquisitions in Animal Feed and Pet
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Nuformix proposes merger with Biovara (November 11, 2026)
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Acrivon Therapeutics Acquires Aqilion’s Drug Development Programs (November 6, 2026)
- Lineage acquires NeuroAirmid Therapeutics (November 12, 2026)
- BioAdaptives, Inc. to acquire Xycota Biosciences LLC to Expand Biotechnology Portfolio (November 4, 2026)
- i-Tail to acquire Phelps Pet Products (November 4, 2026)
Who to call at Dechra, and when
When Dechra changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Dechra raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dechra, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dechra. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dechra makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Gallant?
Gallant was acquired by Dechra, based in Boston. The deal was reported on November 17, 2026. Dechra is privately held and operates in Health Care.
When did Dechra acquire Gallant?
Dechra's acquisition of Gallant was reported on November 17, 2026. Dechra has completed its acquisition of Gallant Pet, Inc., an animal health biotechnology company. This strategic move aims to enhance veterinary care through regenerative medicine and broaden treatment options for complex conditions in pets. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Gallant do?
Gallant is a regenerative medicine company pioneering veterinary therapies that restore health at the source. It is privately held, operating in Other, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.